From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. Clinical Practice Guideline Watch

Preventing Rheumatic Fever: A New Guideline from the AHA

Correct diagnosis and antibiotic treatment of group A streptococcal pharyngitis is necessary for primary prevention of rheumatic fever.

The American Heart Association (AHA) has released a new guideline, endorsed by the American Academy of Pediatrics, which focuses on the prevention of rheumatic fever (RF) and on diagnosis and treatment of acute group A streptococcal (GAS) pharyngitis. Also included in the scientific statement are prophylaxis recommendations for recurrent RF and bacterial endocarditis and discussion of poststreptococcal reactive arthritis and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Although much of the information is not new, the report confirms many recommendations in the AAP Committee on Infectious Diseases’ Red Book. Highlights of the report include the following:

— One third of acute RF episodes result from streptococcal infections that are not evident.

— GAS pharyngitis primarily affects children between ages 5 and 15 years. Infants with GAS infections might present with excoriated nares or purulent nasal discharge. Acute RF is rare in children younger than 3 years.

— Microbiological confirmation is necessary to differentiate GAS pharyngitis from pharyngitis caused by other pathogens. Neither rapid antigen tests nor traditional throat culture can differentiate between people who have GAS infection and those who are carriers.

— Antigen tests are very specific, but sensitivity is unacceptably low. If a patient has a negative rapid test but the clinician has a high index of suspicion for GAS pharyngitis, a culture should be performed.

— Treatment is indicated for patients with acute pharyngitis and either a positive antigen test or a positive culture. In general, follow-up cultures are not recommended.

— Recommended treatments for primary prevention of RF are the following:

  • Penicillin V (250 mg for children ≤27 kg or 500 mg for children >27 kg 2 to 3 times/day for 10 days)
  • Amoxicillin (50 mg/kg once daily [maximum, 1 g] for 10 days)
  • Benzathine penicillin G (1 dose of 600,000 U for children ≤27 kg or 1,200,000 U for patients >27 kg)

— Recommended treatments for patients allergic to penicillin are the following:

  • Clindamycin (20 mg/kg/day divided in 3 doses [maximum, 1.8 g/day] for 10 days)
  • Azithromycin (12 mg/kg/day [maximum dose, 500 mg/day] for 5 days)
  • Clarithromycin (15 mg/kg/day divided in 2 doses [maximum, 250 mg twice per day] for 10 days)

— Repeated courses of antibiotics are rarely indicated in asymptomatic children who continue to be culture positive for GAS.

Comment: This report highlights a number of important points: GAS pharyngitis is one of the few infectious diseases in which penicillin V can be administered twice daily and amoxicillin once daily. If a rapid antigen test is negative but the pretest probability is high (e.g., the patient has sudden onset of sore throat, fever, and pharyngeal exudate), a culture should be performed. Acute RF and the common signs and symptoms of GAS pharyngitis are rare in children younger than 3 years, so you can be more selective about culturing than in older children.

Howard Bauchner, MD

Published in Journal Watch Pediatrics and Adolescent Medicine April 1, 2009

Citation(s):

Gerber MA et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009 Mar 24; 119:1541.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.